Stanford Graduate School of Business (USA)
-
Stanford Management Company in 2018: Venture Capital and Other Asset Allocation
Glynn, John; Lehman, CameronCase SGSB-SM294-EStrategyGreg Milani, Senior Managing Director of the Stanford Management Company, considers how much of Stanford’s $27 billion endowment to allocate to early stage capital, taking into account the various pro’s and con’s of that allocation.Starting at €8.20
-
Verily Life Sciences and Machine Learning
Schulman, Kevin A; Ho, KevinCase SGSB-SM335-EStrategyVerily Life Sciences, an independent subsidiary of Alphabet, Inc., set out to harness machine learning in the health care field. The company sought partnerships with academic research institutions, legacy life sciences companies, and hospitals and health systems to develop tools to collect and organize health data, with the goal of creating platforms that utilized the insights from that data to enhance patient care. The case study discusses these...Starting at €8.20